Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07408141 · ClinicalTrials.gov registry record
MiniMed Fit Payload Wear Study
A clinical trial of Diabetes (Insulin-requiring, Type 1 or Type 2), sponsored by Medtronic Diabetes.
- Recruiting
- Registry status
- 175
- Enrollment target
- 4
- Study locations
NCT07408141 is a study of Diabetes (Insulin-requiring, Type 1 or Type 2) that is actively recruiting participants, run by Medtronic Diabetes. The registered enrollment target is 175 participants. The trial reports 4 study locations across 3 states.
The verdict
NCT07408141, a study of Diabetes (Insulin-requiring, Type 1 or Type 2), is actively recruiting participants, sponsored by Medtronic Diabetes.
- RECRUITING
- Registry status
- 175 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to assess success/failure of the MiniMed Fit Payload adhesive components in different wear locations over a 7-day period to support development of the future commercialized patch pump.
Conditions Studied
Interventions
- DEVICE MiniMed Fit Payload adhesive components
Study Locations (4)
California
- ProSciento - Chula Vista
- Headlands Research California LLC - Escondido
New York
- NYC Research Inc - Long Island City
Washington
- Rainer Clinical Research Center - Renton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2026-02-19 |
| Est. Completion | 2026-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07408141
The ClinicalTrials.gov registry entry for NCT07408141 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Diabetes, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes (Insulin-requiring, Type 1 or Type 2) appearing as the primary indexed condition, and to 1 intervention - of which MiniMed Fit Payload adhesive components is the first listed.
NCT07408141 reports 4 study locations spanning 3 distinct geographic areas - top geographies include California, New York, Washington.
Frequently Asked Questions
What is clinical trial NCT07408141 about?
NCT07408141 is a clinical study titled "MiniMed Fit Payload Wear Study". The purpose of this study is to assess success/failure of the MiniMed Fit Payload adhesive components in different wear locations over a 7-day period to support development of the future commercialized patch pump.
What is the current status of trial NCT07408141?
This trial is currently recruiting. The enrollment target is 175 participants. The study started on 2026-02-19. Estimated completion is 2026-05.
What conditions does trial NCT07408141 study?
This clinical trial studies the following conditions: Diabetes (Insulin-requiring, Type 1 or Type 2).
What interventions are being tested in trial NCT07408141?
The interventions under investigation include: MiniMed Fit Payload adhesive components (DEVICE).
Who is sponsoring clinical trial NCT07408141?
This trial is sponsored by Medtronic Diabetes, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07408141 being conducted?
This trial has 4 study locations across California, New York, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.